Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,21144,129,1.41 [1.09-1.81],0.0083891731667579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,21557,132,1.32 [1.02-1.71],0.0331934948077501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18284,95,0.61 [0.38-0.99],0.0440506439888051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",21144,129,1.47 [1.11-1.94],0.0067062121042977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,18209,92,1.48 [1.12-1.96],0.0061806639597827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,21332,132,2.08 [1.21-3.58],0.0083492145384217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18284,95,1.85 [1.07-3.18],0.026370784705239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18745,97,1.89 [1.04-3.44],0.0378345002519526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,18284,95,1.73 [1.08-2.78],0.022625126887672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,18852,99,2.08 [1.27-3.41],0.0035452771441175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,18873,98,1.56 [1.18-2.05],0.001725668055794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,21724,133,2.47 [1.36-4.48],0.0029880731066873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,21644,130,1.74 [1.19-2.54],0.0041444365268007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",18334,92,0.71 [0.52-0.98],0.0378950678304224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18284,95,1.32 [1.03-1.67],0.0252928970331443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,21821,134,2.28 [1.07-4.85],0.0327375578781969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,21690,133,2.77 [1.35-5.68],0.0052980589504428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,21446,131,2.21 [1.15-4.22],0.0170425055015584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,21724,133,2.25 [1.57-3.22],8.88511116608786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,21255,128,2.44 [1.43-4.17],0.0010304236797313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,21610,130,2.00 [1.42-2.82],8.09892287236508e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,21640,132,1.69 [1.00-2.84],0.0494052111081748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,18095,94,1.38 [1.10-1.72],0.0053028846607885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,21693,134,1.27 [1.03-1.58],0.0259223316264551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,21446,131,1.83 [1.35-2.49],0.0001160088179364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,18873,98,1.52 [1.04-2.20],0.0296108274185862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",21644,130,2.28 [1.34-3.88],0.0023534668460961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21052,127,1.32 [1.05-1.65],0.0162314206617079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,21052,127,1.63 [1.01-2.64],0.0466279159902048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,21578,131,2.09 [1.15-3.82],0.0163310182761191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,21365,132,0.56 [0.36-0.87],0.0105747263637587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,18516,96,0.50 [0.31-0.81],0.0050075263324241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,18757,97,0.47 [0.27-0.83],0.00912569729568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,18378,94,0.67 [0.46-0.97],0.0329683871670879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,18209,92,1.35 [1.01-1.80],0.0408198039107777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,21736,131,2.98 [1.47-6.05],0.0025158314762113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,21644,130,1.83 [1.08-3.10],0.023529741893472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,21055,131,1.23 [1.00-1.50],0.049473859556395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,21668,131,2.87 [1.51-5.45],0.0012850694938907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,17894,95,1.53 [1.10-2.12],0.0121041730853322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,18873,98,3.59 [1.09-11.84],0.0358253642555266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,18398,97,3.71 [2.09-6.58],7.626293858884979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,21446,131,1.98 [1.28-3.07],0.0022931884020044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,18284,95,1.60 [1.06-2.40],0.025157164123623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,21446,131,1.66 [1.19-2.31],0.0028200397332634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,21052,127,1.42 [1.02-1.97],0.0376380645795202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,21362,132,1.32 [1.03-1.69],0.0270931300921073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,18757,97,1.52 [1.10-2.09],0.0116291437811523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,21557,132,2.04 [1.42-2.92],0.0001065731786827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,18378,94,1.35 [1.01-1.82],0.04413525203132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,21768,132,1.61 [1.06-2.45],0.0240197118166043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,21526,132,1.60 [1.16-2.19],0.0036760730358458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,21821,134,1.41 [1.02-1.95],0.0391676367877525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,21821,134,1.40 [1.03-1.92],0.0326454319585622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,21519,130,1.22 [1.03-1.44],0.0198504784550179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,21768,132,1.18 [1.02-1.36],0.0300254933513909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,21644,130,1.47 [1.11-1.93],0.0066909683558622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,21363,130,1.42 [1.08-1.86],0.0113311286537455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,21644,130,1.77 [1.24-2.54],0.0016797063213594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,21768,132,1.57 [1.15-2.15],0.0048455947740274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,21429,131,1.31 [1.03-1.67],0.0283737291669666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,21581,130,1.20 [1.01-1.44],0.041860452774761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,21786,134,1.82 [1.22-2.71],0.0035561194553182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,21578,131,1.85 [1.25-2.72],0.0019578512268222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,21172,130,1.52 [1.07-2.16],0.0186065928092687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,21637,130,1.64 [1.18-2.29],0.0032948773618679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,21365,132,1.72 [1.16-2.53],0.0067214020809009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,21549,130,2.61 [1.69-4.03],1.5304585871564e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,21446,131,2.15 [1.40-3.32],0.0004894008978987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,20823,128,2.04 [1.17-3.56],0.0120212985981954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,21734,134,1.76 [1.16-2.67],0.0074831850658636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,21768,132,1.50 [1.11-2.02],0.0084984604648995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,21578,131,2.66 [1.30-5.45],0.0076245857109063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,21701,134,1.25 [1.02-1.54],0.0292355260807674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,21557,132,1.67 [1.14-2.45],0.0080943357377836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,21702,131,1.47 [1.04-2.07],0.030909405556849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21144,129,1.53 [1.15-2.02],0.003288164742897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,18501,97,1.36 [1.05-1.77],0.0208839602039222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,18873,98,2.21 [1.05-4.63],0.0364292057632295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18809,98,2.03 [1.37-3.00],0.0003938290378859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,18852,99,1.22 [1.02-1.45],0.0270523252010433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,21131,129,1.30 [1.09-1.54],0.0028704029308158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,21610,130,2.19 [1.37-3.48],0.0009836688082975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,18852,99,1.52 [1.04-2.22],0.0294055705031038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,18501,97,0.43 [0.24-0.77],0.0043282440755373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,21674,131,2.28 [1.52-3.42],6.118263444037152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,18852,99,1.68 [1.22-2.31],0.0014879417735679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,21545,131,1.52 [1.10-2.09],0.0105416401904358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,21505,131,0.70 [0.51-0.96],0.0286369396303068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,21505,131,1.32 [1.04-1.68],0.0211315357137634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,21495,132,1.94 [1.19-3.14],0.0074497824474115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,21724,133,2.71 [1.44-5.11],0.0021009667732187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,21768,132,2.18 [1.63-2.93],1.9848293357207746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,18873,98,1.57 [1.06-2.32],0.0250610930213736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,21667,133,3.92 [2.13-7.23],1.1825390975299397e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,21557,132,2.09 [1.47-2.98],4.005678747298759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,21821,134,2.16 [1.51-3.09],2.819567932499156e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,21549,130,2.33 [1.39-3.92],0.0013652071972806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,18213,94,1.84 [1.23-2.76],0.0031006191405184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,18843,97,2.18 [1.32-3.61],0.0024390320137065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,21549,130,1.76 [1.00-3.08],0.0491966808876942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,21644,130,2.73 [1.32-5.64],0.0067492714573531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,21365,132,1.68 [1.27-2.23],0.0003017630819965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,21644,130,2.65 [1.57-4.47],0.0002747777960278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,18209,92,1.32 [1.12-1.54],0.000606110302237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,21638,132,2.00 [1.25-3.21],0.0039026683825872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,21581,130,1.24 [1.10-1.40],0.0006118304789436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,21269,131,1.89 [1.36-2.63],0.0001418470152379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,21604,134,1.51 [1.16-1.96],0.0022102176989701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,16851,104,3.09 [1.47-6.48],0.0028104689415726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,18334,92,0.51 [0.26-0.99],0.0481886393357502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,21505,131,1.40 [1.06-1.86],0.0190451867253626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,21793,134,2.45 [1.31-4.58],0.0051605692076659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,21768,132,1.47 [1.04-2.08],0.0276223173216218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,21397,132,1.26 [1.06-1.51],0.0102583119196921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,21644,130,1.36 [1.10-1.67],0.0040995408070819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,18284,95,1.28 [1.00-1.63],0.0466245138902102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,21481,130,1.25 [1.03-1.53],0.0274022232298867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,18334,92,0.30 [0.10-0.90],0.0312801178458522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21446,131,1.41 [1.02-1.95],0.0386491111802177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,21734,134,2.72 [1.48-5.00],0.0013048597717636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,18213,94,1.37 [1.11-1.70],0.0036014358985208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,21821,134,1.81 [1.10-2.98],0.0187607794370977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,21637,130,2.11 [1.32-3.37],0.0017200562135048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,21821,134,4.27 [2.20-8.27],1.7130347181842906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,21643,133,1.32 [1.05-1.65],0.0170434697906193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,21356,130,1.78 [1.18-2.67],0.005514938787004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,18806,96,0.55 [0.32-0.96],0.0350972692541616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,21578,131,1.76 [1.02-3.05],0.0434826002780931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,21645,133,1.61 [1.05-2.46],0.0287744843637676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,18713,97,2.21 [1.51-3.23],4.188763912546517e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,21446,131,2.90 [1.83-4.62],6.508802652309494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,18334,92,1.28 [1.02-1.62],0.0365135812874552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,18334,92,0.71 [0.52-0.96],0.024530749423105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,21686,133,1.94 [1.20-3.14],0.0067106099494411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,18213,94,0.51 [0.29-0.92],0.0253816832651337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,21724,133,2.42 [1.74-3.38],1.9423965800312095e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,21144,129,1.54 [1.00-2.37],0.049005383425668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,18378,94,2.72 [1.44-5.13],0.0019755956606514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21643,132,1.92 [1.21-3.04],0.0056456662975602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,21546,130,1.96 [1.22-3.15],0.0054250998049739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,21332,132,1.85 [1.22-2.80],0.0036173655667752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,18843,97,2.07 [1.22-3.50],0.0066665149769098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,21136,129,1.69 [1.28-2.22],0.0001880008687587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,21821,134,2.36 [1.01-5.51],0.0462355637892591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,21144,129,2.14 [1.14-4.03],0.0183776000767759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,20772,123,2.13 [1.51-3.00],1.814183566847923e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,21821,134,2.35 [1.38-4.01],0.0017129108646203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,21332,132,1.89 [1.21-2.95],0.0052192372202689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,18501,97,0.39 [0.21-0.73],0.0034844478199688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21681,133,1.65 [1.03-2.65],0.0383606970731301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,21821,134,1.70 [1.08-2.67],0.0216338806063315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,18165,95,1.50 [1.09-2.07],0.0121855980529096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,18614,97,1.69 [1.11-2.58],0.0144360843145196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",21549,130,1.21 [1.03-1.41],0.0186726063914242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",18843,97,1.80 [1.32-2.46],0.0001892407865095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",21821,134,1.71 [1.31-2.23],8.166282131453974e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,21651,133,1.26 [1.01-1.57],0.0414765886062524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,21505,131,0.73 [0.55-0.97],0.0314835008653766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,21515,132,2.32 [1.45-3.71],0.0004360455435313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,18334,92,0.66 [0.47-0.94],0.0209392939130982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,21052,127,1.25 [1.02-1.53],0.0315823224858945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",18209,92,1.40 [1.12-1.76],0.0036932626175358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,21505,131,1.27 [1.03-1.58],0.0279665971816136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,21693,133,1.46 [1.18-1.81],0.0004971366459692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,21136,129,1.67 [1.09-2.58],0.0198018289942416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,21637,130,2.23 [1.15-4.31],0.0168943980213534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,18856,97,1.41 [1.06-1.88],0.0188816339604704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,21365,132,1.93 [1.14-3.29],0.0152543102111024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,21410,131,2.48 [1.59-3.86],6.281184152847503e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,21514,130,2.59 [1.72-3.90],4.706042973660358e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,18757,97,1.56 [1.17-2.08],0.0024562994398394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,21699,134,2.19 [1.19-4.02],0.012027089282332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,21052,127,1.17 [1.03-1.32],0.0144062747399018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,21821,134,2.27 [1.80-2.86],3.48596645004276e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,21015,126,2.10 [1.58-2.80],3.356705775165527e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,21052,127,1.28 [1.00-1.64],0.0466261251919219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,21686,133,3.61 [2.32-5.64],1.5115824551752323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,21546,130,1.40 [1.05-1.86],0.0209727752098289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,18442,92,0.46 [0.23-0.95],0.035118890324386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,18809,98,2.04 [1.16-3.59],0.0136522438961287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20875,129,1.24 [1.05-1.47],0.0099622537126165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,21724,133,1.83 [1.10-3.05],0.0202554627350584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,18757,97,1.45 [1.04-2.03],0.0295899237799762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,18757,97,1.40 [1.05-1.88],0.0236203378747155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,21473,129,1.84 [1.00-3.40],0.0499968624131692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",21446,131,1.34 [1.05-1.70],0.0189540937651218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,18501,97,1.25 [1.03-1.51],0.0255861933601752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,21690,133,1.49 [1.20-1.84],0.0003034319376134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,21578,131,1.64 [1.09-2.46],0.01700686895264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,21684,132,1.19 [1.01-1.41],0.0335761640807054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,21768,132,2.24 [1.52-3.30],4.599923132650145e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,21052,127,0.62 [0.41-0.96],0.0327303377414362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,21724,133,2.46 [1.76-3.44],1.2326463809405226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21417,130,1.73 [1.03-2.90],0.0381553838580403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,18213,94,0.52 [0.29-0.92],0.0247918727438057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21055,131,1.33 [1.01-1.75],0.0410052887347794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,21644,130,2.39 [1.27-4.49],0.0067111187273121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,18209,92,1.50 [1.06-2.13],0.0231379072111495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,21785,134,1.16 [1.02-1.32],0.0206628212196555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,21795,134,1.75 [1.36-2.26],1.6620665710772542e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,21301,129,1.92 [1.47-2.52],2.081775008426969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,21821,134,2.07 [1.51-2.84],6.003997649063742e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,21557,132,1.88 [1.25-2.83],0.0025530490443446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,18835,98,1.91 [1.30-2.82],0.0010960756799712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,21505,131,1.94 [1.27-2.97],0.0023565827622075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,21136,129,1.21 [1.00-1.46],0.0450975310034794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,21484,130,1.51 [1.10-2.06],0.0107381284169462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,21011,129,1.29 [1.06-1.57],0.0098753658425573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,21037,128,1.38 [1.09-1.74],0.0069243525571985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,21546,130,2.98 [1.62-5.48],0.0004594783901599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,21510,130,1.45 [1.13-1.85],0.003200684129691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,21505,131,1.41 [1.02-1.96],0.0379783720253237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,18207,95,1.36 [1.11-1.66],0.0032291288294141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,21505,131,1.73 [1.19-2.52],0.0044796275475813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,21136,129,1.10 [1.00-1.21],0.0439125969768773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,21505,131,1.44 [1.12-1.86],0.0049315573439792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,21446,131,1.25 [1.07-1.46],0.0052973734657208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,21557,132,2.76 [1.20-6.33],0.0168546082305797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,18757,97,1.53 [1.07-2.20],0.0198302384969108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,21505,131,0.57 [0.37-0.90],0.0153784111169139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,18442,92,0.50 [0.28-0.89],0.018820932284371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,21724,133,0.38 [0.15-0.96],0.0408425799675589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,21052,127,1.49 [1.02-2.17],0.0370805650533791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,18852,99,1.56 [1.02-2.39],0.0423778192492348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21671,132,2.01 [1.33-3.02],0.0008170984117922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,18873,98,2.01 [1.04-3.85],0.0366109772223933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,21734,134,2.11 [1.28-3.46],0.0032484033228758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,21432,128,1.55 [1.07-2.25],0.0214408937788898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,21724,133,1.45 [1.06-1.98],0.0194305712321553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,21724,133,1.41 [1.14-1.74],0.0014375002316074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",18209,92,1.60 [1.10-2.31],0.0132090586763962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",21464,131,1.26 [1.03-1.56],0.027599048672801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21549,130,1.69 [1.22-2.33],0.0013780342006126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,21644,130,1.71 [1.09-2.66],0.0188831023617916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,21332,132,1.75 [1.19-2.57],0.0040593425599066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,18843,97,1.45 [1.10-1.92],0.0094787835160973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,21557,132,1.73 [1.15-2.61],0.0082127933369514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,21549,130,1.40 [1.08-1.81],0.0106258404375171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,21457,132,1.56 [1.18-2.07],0.001643695586872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,21547,130,1.65 [1.03-2.63],0.0369901021716395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,21136,129,1.47 [1.05-2.05],0.0241235200720961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,18806,96,2.33 [1.64-3.31],2.3697645658697807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,18873,98,2.24 [1.12-4.46],0.0223222471706591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18221,95,1.76 [1.05-2.94],0.0305834629063038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,21557,132,1.91 [1.29-2.84],0.0012419743187755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,21136,129,0.61 [0.41-0.91],0.0141731046269097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,18334,92,1.66 [1.23-2.25],0.0009613350805506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,21821,134,2.58 [1.68-3.98],1.676481964602369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,21457,130,2.05 [1.27-3.29],0.0030629461205501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,21446,129,1.65 [1.17-2.31],0.0041514818879468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21288,132,1.28 [1.01-1.62],0.0378214666153155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,18501,97,0.80 [0.68-0.94],0.0060924302854672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,18209,92,1.29 [1.05-1.57],0.0140451544724304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,21582,130,2.57 [1.53-4.30],0.0003492315063916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,21821,134,1.43 [1.11-1.84],0.0053356774401376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,21365,132,1.26 [1.01-1.58],0.0441840348550332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,21583,130,1.48 [1.19-1.85],0.0004141308435581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,21768,132,1.83 [1.01-3.33],0.0471088027265562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,21505,131,1.22 [1.02-1.46],0.0276754785608345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,21500,129,1.30 [1.02-1.66],0.0358658023380936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,21108,129,1.74 [1.25-2.42],0.0009078819381806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,21693,134,1.35 [1.12-1.64],0.0019909858476154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,21541,131,1.40 [1.09-1.81],0.0096320815806207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",18209,92,1.48 [1.06-2.06],0.0228195585553457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,21578,131,1.34 [1.00-1.81],0.04995010373256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",18843,97,1.40 [1.10-1.77],0.0061135498494027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,18378,94,1.30 [1.00-1.69],0.0484757233680242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,18344,94,0.69 [0.47-1.00],0.0484311049810394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,18701,97,0.62 [0.41-0.94],0.0239767099657155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,21637,130,2.43 [1.43-4.11],0.0009670661789587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,21136,129,0.53 [0.33-0.87],0.0120874261040352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,21724,133,2.69 [1.62-4.49],0.000140727970612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,21515,132,1.96 [1.23-3.11],0.0043834198732637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,21637,130,1.66 [1.10-2.50],0.0156721280868213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,20993,130,1.70 [1.25-2.30],0.0006346161205547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,21768,132,1.77 [1.06-2.97],0.0286910196637796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,18501,97,0.53 [0.29-0.95],0.0333495198852515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,21052,127,1.38 [1.03-1.86],0.0325021306880372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",21055,131,1.44 [1.10-1.88],0.0077507512881446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,21821,134,1.71 [1.09-2.68],0.0190601009302675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,18527,98,1.70 [1.08-2.67],0.0228157558530571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,21557,132,2.17 [1.50-3.12],3.201582976030288e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,21144,129,1.23 [1.11-1.38],0.0001666954850348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,21700,132,2.14 [1.26-3.64],0.0048092865047979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,18809,98,2.16 [1.57-2.98],2.638838097025606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,21557,132,1.27 [1.13-1.43],4.982021279051946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,18806,96,1.72 [1.18-2.50],0.004524287275311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,21578,131,1.66 [1.19-2.31],0.0026349680701692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,21351,130,1.31 [1.05-1.65],0.0190789626864896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,21446,131,0.72 [0.58-0.91],0.005775868817831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,18809,98,0.46 [0.22-0.94],0.03322277939457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,21582,130,1.62 [1.04-2.54],0.0347803701890092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,21413,131,1.35 [1.08-1.67],0.0070795320451065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,18809,98,2.37 [1.57-3.57],3.9036690506922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,21719,134,2.08 [1.17-3.69],0.0127618678918369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,18501,97,0.71 [0.52-0.97],0.0333831865478437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,18745,97,0.58 [0.35-0.98],0.0412565344106116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,21557,132,1.70 [1.01-2.87],0.0467453891741629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,18856,97,0.36 [0.17-0.74],0.0051338110838097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,21768,132,2.24 [1.36-3.69],0.0016347582257059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,21732,134,1.46 [1.06-2.01],0.0222560927407288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21365,132,2.41 [1.47-3.93],0.0004537107570236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,21307,132,1.58 [1.26-1.99],7.521828672168118e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,21290,129,2.01 [1.34-3.02],0.0007256294471639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21578,131,1.96 [1.23-3.13],0.004955932764528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,21578,131,1.50 [1.04-2.16],0.0306142591616839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,21637,130,1.88 [1.08-3.27],0.025116147241318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,21418,130,3.69 [2.31-5.91],5.1337445420734544e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,18406,97,3.19 [1.64-6.22],0.0006604605992685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,21055,131,1.56 [1.08-2.25],0.0190889936629256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,21710,134,1.95 [1.07-3.55],0.0290075177033568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",21446,131,1.42 [1.01-1.99],0.0440666365564678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,18856,97,0.51 [0.29-0.90],0.0191991730922217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,18521,97,0.69 [0.49-0.95],0.0246403907852913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,21549,130,2.55 [1.35-4.82],0.0040255452218764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,18852,99,1.45 [1.02-2.06],0.0404841236756775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,21505,131,1.47 [1.13-1.92],0.0039441837997647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,18284,95,1.48 [1.05-2.07],0.0233512872490025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,18284,95,1.61 [1.12-2.31],0.0102925268241134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,21724,133,1.88 [1.02-3.44],0.0421253788156734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,18165,95,0.47 [0.24-0.92],0.0273266704240136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,21734,134,2.24 [1.56-3.22],1.2724939967941733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,21612,133,2.72 [1.67-4.45],6.239190366209972e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,18512,96,1.51 [1.17-1.93],0.0012636199453494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,21052,127,0.54 [0.36-0.82],0.0034841540875303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,18284,95,1.25 [1.02-1.53],0.0302831826476527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,18806,96,2.06 [1.53-2.78],1.96817036501833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,21429,130,1.45 [1.11-1.90],0.0062900731670038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,21821,134,1.38 [1.09-1.74],0.0073943360131173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,21821,134,1.38 [1.12-1.70],0.0029930547758111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,21582,130,1.89 [1.46-2.45],1.759007436606352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,21578,131,1.85 [1.16-2.95],0.0098303564564342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,21557,132,1.27 [1.08-1.50],0.0034249843329881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,21524,132,1.58 [1.15-2.17],0.0051979585998337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,21136,129,0.69 [0.50-0.95],0.0246067264826266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,18728,97,1.54 [1.03-2.30],0.0362601679693605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,21736,133,2.18 [1.37-3.45],0.0009467407166955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,21557,132,1.64 [1.02-2.62],0.0398367156954451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,21365,132,1.74 [1.16-2.60],0.0074432692233178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,21724,133,2.82 [1.86-4.28],1.0880138892446838e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,21724,133,1.72 [1.14-2.59],0.0091124735758972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,21388,132,1.41 [1.10-1.80],0.0071794864934797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,18284,95,1.59 [1.01-2.48],0.0432610403490411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,18873,98,1.54 [1.10-2.16],0.0123452633123292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,21734,134,1.76 [1.09-2.86],0.0215378624834262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,20959,131,1.93 [1.30-2.87],0.0012149888255796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,21734,134,2.53 [1.57-4.09],0.0001359143001829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,21609,133,1.65 [1.06-2.57],0.0277015544164667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,21610,130,1.19 [1.02-1.38],0.0230080295790456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,21446,131,1.73 [1.17-2.54],0.0054702301510892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,21821,134,1.95 [1.33-2.85],0.0005960698103718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,18841,98,2.98 [1.06-8.37],0.0387246795500368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,21302,132,1.90 [1.44-2.50],5.023002405314703e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,21052,127,1.34 [1.02-1.76],0.0388242374685776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,18852,99,1.78 [1.10-2.89],0.0191878680964495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,21618,134,1.38 [1.03-1.85],0.0286838044555046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,21136,129,1.31 [1.01-1.72],0.0453532125784669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,21052,127,1.51 [1.12-2.03],0.0062227885785211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,21724,133,1.98 [1.30-3.01],0.0015563404356323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,21644,130,1.67 [1.14-2.45],0.0083532370872517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,21365,132,1.67 [1.32-2.11],1.638271334815084e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,18806,96,1.48 [1.07-2.04],0.0175257941461465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,21578,131,1.85 [1.38-2.49],4.450361915771212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,21505,131,1.30 [1.05-1.60],0.0151399341407677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,21724,133,1.43 [1.06-1.93],0.0203803682885876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,21512,130,2.03 [1.18-3.52],0.011128757353622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,21644,130,1.55 [1.05-2.30],0.0272359963574543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,21582,130,2.36 [1.77-3.14],4.8722722429186255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,21452,131,1.88 [1.23-2.87],0.0037285523984859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,21795,134,1.39 [1.00-1.92],0.0487148084429809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,18843,97,2.01 [1.18-3.42],0.0102413783499892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,21734,134,1.39 [1.01-1.91],0.0448734980453869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,19036,114,1.86 [1.27-2.74],0.001502747584509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,21446,131,1.76 [1.21-2.58],0.003271564622769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,21344,132,0.85 [0.73-0.99],0.034050372732805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,21795,134,1.63 [1.07-2.50],0.0240540845946658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,18334,92,0.63 [0.44-0.90],0.0120911365181955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,21471,130,1.28 [1.09-1.52],0.0035386321310694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,21610,130,1.59 [1.26-2.02],0.0001263969812629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,21553,132,1.58 [1.23-2.02],0.0003777631175548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,21505,131,1.46 [1.07-1.97],0.0156005634324945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,21637,130,1.76 [1.20-2.58],0.003604987210791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,21578,131,1.68 [1.18-2.40],0.0040765014098812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,21589,132,1.53 [1.10-2.14],0.0118339825595682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,21353,131,1.99 [1.23-3.22],0.0053575881982391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,21578,131,1.34 [1.09-1.65],0.0055538580457793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,21671,132,1.46 [1.07-1.98],0.0163999817224048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21365,132,1.74 [1.25-2.43],0.0011270143954253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21365,132,1.36 [1.12-1.66],0.0022607445900478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21768,132,1.60 [1.12-2.28],0.0089691297809125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21549,130,3.13 [1.97-4.96],1.2704449741470276e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21637,130,1.76 [1.18-2.63],0.0054374881191384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21582,130,1.84 [1.39-2.43],1.6392490943957266e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21582,130,1.98 [1.26-3.11],0.0030906162376051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21724,133,2.06 [1.40-3.04],0.0002485639357448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21578,131,2.17 [1.43-3.31],0.0003023559981863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21578,131,1.45 [1.06-1.99],0.019208251115004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21365,132,1.31 [1.03-1.67],0.0268978040021124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21768,132,0.43 [0.24-0.78],0.0051697988682742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,21505,131,0.72 [0.56-0.94],0.0140468251843696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21793,134,1.63 [1.00-2.66],0.0487638193326043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,21724,133,1.33 [1.04-1.70],0.0212530067026405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,18209,92,1.35 [1.01-1.81],0.0416005943679729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,18209,92,1.49 [1.19-1.88],0.000642769229538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,18809,98,1.56 [1.07-2.26],0.0197277172790274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,21734,132,1.55 [1.02-2.36],0.0383127954420449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,18757,97,1.50 [1.17-1.93],0.0013199949481844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,21549,131,1.56 [1.11-2.20],0.0108813687351509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,20482,122,2.04 [1.49-2.79],7.72561482780702e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,21724,133,2.07 [1.34-3.21],0.0010254282681245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,21136,129,1.79 [1.13-2.84],0.0125871605194871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,21724,133,1.29 [1.00-1.65],0.046378358032198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,21730,134,1.94 [1.31-2.87],0.0009761517584009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,21637,130,0.83 [0.72-0.96],0.0137258783107073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,18809,98,3.52 [1.96-6.33],2.5828409165836088e-05
